S. Johnston - Concepedia

Author

S. Johnston

Also Known As

JOHNSTON, SRD, Johnston S, Johnston, SRD, S Johnston, S R D Johnston, S R Johnston, S. Johnston, S. R. D. Johnston, S. R. Johnston, S.R.D. Johnston

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Royal Marsden Hospital Institute of Cancer Research Royal Marsden NHS Foundation Trust Institut Gustave Roussy Centre Jean Perrin

About

S. Johnston is an author at Royal Marsden Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	552
2	Health Sciences	1	1	51
3	Public Health	1	2	40
4	Cell Biology	1	1	70
5	Endocrinology	1	1	61

S. Johnston

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) Fátima Cardoso, Elżbieta Senkus, A. Costa, Annals of Oncology	2018	1.1K
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3 M.P. Goetz, M. Toi, Jens Huober, Annals of Oncology	2024	177
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration S. Johnston, Mitch Dowsett, IE Smith, The Lancet Breast OncologyOncologyMedicineHuman Breast CancerBreast Cancer	1993	87
Gene Therapy with Autologous, Interleukin 2-Secreting Tumor Cells in Patients with Malignant Melanoma Kay Palmer, J. Moore, M. Everard, Human Gene Therapy	1999	80
Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay. Gloria Saccani Jotti, S. Johnston, Janine Salter, Journal of Clinical Pathology	1994	79
Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen S. Johnston, KA MacLennan, N.P.M. Sacks, European Journal of Cancer Breast OncologyOncologyMedicineKi-67 ExpressionBreast Cancer	1994	70
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer Joyce O’Shaughnessy, Mario Campone, Étienne Brain, Annals of Oncology	2015	63
Clinical and endocrine effects of the oral aromatase inhibitor vorozole in postmenopausal patients with advanced breast cancer. S. Johnston, Ian E. Smith, David R. Doody, PubMed Breast OncologyGynecologyPharmacotherapyEndocrine EffectsPre-clinical Pharmacology	1994	61
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer Stefan Michiels, Lina Pugliano, Sophie Marguet, Annals of Oncology Progression-free SurvivalBreast OncologyOncologyHer2-targeted AgentsSurrogate End Point	2016	59
Positron emission tomography/computed tomography in the management of recurrent/metastatic breast cancer: a large retrospective study from the Royal Marsden Hospital Anastasia Constantinidou, Antonio Félix Conde-Martín, Bhupinder Sharma, Annals of Oncology Breast OncologyOncologic ImagingMedical ImagingMedicineCancer Management	2010	51

Page 1